Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urologica e Nefrologica 2016 December;68(6) > Minerva Urologica e Nefrologica 2016 December;68(6):586-91

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

REVIEWS  ENDOUROLOGIC DISEASE GROUP FOR EXCELLENCE (EDGE) RESEARCH CONSORTIUM: A PRIMER ON ADVANCED URETEROSCOPY FOR STONE DISEASE 

Minerva Urologica e Nefrologica 2016 December;68(6):586-91

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Understanding the costs of flexible ureteroscopy

Justin B. ZIEMBA, Brian R. MATLAGA

Brady Urological Institute, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA


PDF


Ureteroscopy (URS) is the first line treatment for the majority of symptomatic renal and ureteral stones. This review summarizes the current literature on the costs associated with URS. A high initial investment is required for scope acquisition. Once purchased, maintenance and repair costs continue to accrue. Durability of the scopes is an important consideration as more durable scopes will remain functional for longer and thus have lower overall repair costs. Currently available, newer generation scopes appear highly durable compared to their predecessors. Ancillary equipment, mostly disposable items represent the highest per procedure cost of URS. Despite these costs, URS remains highly profitable. However, it is also efficacious demonstrating superior cost-effectiveness with higher stone free rates at a lower cost relative to shock wave lithotripsy.

top of page